Valuation Ratios of Alder BioPharmaceuticals, Inc. (ALDR) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Alder BioPharmaceuticals, Inc. (ALDR). These ratios are important while doing valuation of the company or the shares of the company.
Alder BioPharmaceuticals, Inc. (ALDR) currently has P/E (Price to Earnings) ratio of 0 while the company’s industry has 62.47 P/E and the sector P/E is 22.92. Similarly, the company’s last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry’s and sector’s high P/E for the past year is 33.97 and 46.16 respectively and low P/E ratio for the last 5 years is 11.69 for the industry and 13.97 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, ALDR has Beta of 1.03 while its industry and Sector’s beta remains at 1.15 and 0.94 respectively.
Price to Sale ratio of ALDR stands at 22.55 while Price to Book Ratio stands at 2.73. Its Price to Cash Flow ratio shows the value of 0, whereas, the industry and sector ratio of Price to Cash Flow ticked at 44.22 and 26.91 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the industry’s and the sector’s growth for next 5 years ticked at 6.9 and 6.72 respectively.
Alder BioPharmaceuticals, Inc. (ALDR) Trading Statistics:
The company declined -2.51% and closed its last trading session at $11.95. The market capitalization of the company is at $602.42 Million. The stock touched 52-week High of $36.48 on 08/24/16 and 52-week Low of $10.05 on 07/12/17. The stock currently has Weekly Volatility of 9.97% and Monthly Volatility of 8.44%. The Average True Range (ATR) shows a value of 1.25.